Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats

Oncology Reports

Volumn 4, Issue 6, 1997, Pages 1271-1273

  Joarder, Farahnaz S ^a   Abou Issa, Hussein ^a,b   Robertson, Fredika M ^a,b   Parrett, Michelle L ^a   Alshafie, Galal ^a   Harris, Randall E ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Ibuprofen; Mammary cancer; NSAIDs; Sprague Dawley rat

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; IBUPROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; DRUG EFFECT; FEMALE; GROWTH INHIBITION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

EID: 0030882975     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.6.1271     Document Type: Article

References (36)

1. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, Sigman CC, Boone CW and Kelloff GJ: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention drug development program. J Cell Biochem 20 (Suppl): 32-54, 1994.
2. Reddy BS, Tokumo K, Kulkarni N, Aligia C and Kelloff G: Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13: 1019-1023, 1992.
3. Cornwall H, Odukoya O and Shklar G: Oral mucosal tumor inhibition by ibuprofen. J Oral Maxillofac Surg 41: 795-800, 1983.
4. Jalbert G and Castonguay A: Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett 66: 21-28, 1992.
5. Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberts DS, Covey JM, Doody LA, Knapp GG, et al: Clinical development plan: ibuprofen. J Cell Biochem 20 (Suppl): 197-204, 1994.
6. Thun MJ, Namboodiri MM and Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596, 1991.
7. Schreinemachers DM and Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138-146, 1994.
8. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R and Fraumeni JF Jr: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307-311, 1993.
9. Muscat JE, Stellman SD and Wynder EL: Analgesic use and colorectal cancer. Prev Med 24: 110-112, 1995.
10. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A and Willett WC: Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-246, 1994.
11. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD and Shapiro SA: A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 83: 355-358, 1991.
12. Greenburg ER, Baron JA, Freeman DH, Mandel JS and Haile R: Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 85: 912-916, 1993.
13. Harris RE, Namboodiri KK and Farrar WB: Epidemiological study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 2: 591-592, 1995.
14. Harris RE, Namboodiri KK and Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7: 203-205, 1996.
15. Harris RE, Namboodiri KK, Stellman SD and Wynder EL: Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med 24: 119-120, 1995.
16. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ and Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11693-11697, 1994.
17. Ara G and Teicher BA: Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostagland Leuk Essent Fatty Acids 54: 3-16, 1996.
18. Parrett ML, Harris RE, Joarder FS, Clausen KP and Robertson FM: Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 10: 503-507, 1997.
19. Fulton AM and Levy JG: Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin. Int J Cancer 26: 669-673, 1980.
20. Lee PP and Ip MM: Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase. Prostalgand Leuk Essent Fatty Acids 45: 21-31, 1992.
21. Carter CA, Milholland RJ, Shea W and Ip MM: Effect of prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res 43: 3559-3562, 1983.
22. Fulton AM: In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res 44: 2416-2420, 1984.
23. McCormick DL, Madigan MJ and Moon RC: Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res 45: 1803-1808, 1985.
24. Shah A and Jung D: Dose-dependent pharmacokinetics of ibuprofen in the rat. Drug Metab Dispos 15: 151-154, 1987.
25. Davies NM, Wright MR and Jamali F: Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharmaceut Res 11: 1652-1656, 1994.
26. Tahamont MV and Gee MH: The effects of cyclooxygenase inhibition of chemiluminescence and aggregation in sheep neutrophils. Prostagland Leuk Med 24: 139-149, 1986.
27. Marnett LJ: Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev 13: 241-256, 1994.
28. Herschman HR: Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 13: 241-256, 1994.
29. Goppelt-Struebe M: Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostagland Leuk Essent Fatty Acids 52: 213-222, 1995.
30. O'Neill GP and Ford-Hutchinson AW: Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330: 156-160, 1993.
31. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and Dubois RN: Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
32. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589, 1992.
33. Liu XH and Rose DP: Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56: 5125-5127, 1996.
34. Zhao Y, Agarwal VR, Mendelson CR and Simpson ER: Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137: 5739-5742, 1996.
35. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR and Bulun SE: Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Rev 15: 342-355, 1994.
36. Dickson RB and Lippman ME: Molecular basis of breast cancer. In: The Molecular Basis of Cancer. Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds). W.B. Saunders Company, Philadelphia, PA, 1995.